Minerva Neurosciences

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$42
$42
$0
Gross Profit
-1
21
21
-5
EBITDA
-3,257
-4,270
-4,271
22,519
EBIT
-3,258
-4,272
-4,272
22,513
Net Income
-3,258
-3,752
-4,272
22,513
Net Change In Cash
0
42
42
0
Free Cash Flow
-6,114,092,833
-5,166
-5,166
-14,383,772,968
Cash
15,247
17,290
21,362
26,528
Basic Shares
7,568
7,569
7,569
7,569

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-22
-30
-8
-102
EBITDA
6,024
-21,691
-24,694
-51,608
EBIT
6,001
-21,721
-24,702
-51,709
Net Income
1,439
-30,005
-32,109
-49,906
Net Change In Cash
0
0
0
0
Free Cash Flow
-19,550
-14,784
-24,661
-24,601
Cash
21,362
40,912
36,093
60,755
Basic Shares
7,574
6,506
5,340
5,340

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.43
2025-03-31
-$0.50
2024-12-31
-$0.56